3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
13
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
4
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Fruquintinib
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Ampullary Adenocarcinoma
1
Interventions
Liquid Biopsy
4
Blood Specimen Collection
4
Gemcitabine
3
pembrolizumab
2
Immunohistochemistry
2
Cisplatin
2
Capecitabine
2
Base Sequence
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
taxane
1
lenvatinib
1
irinotecan sucrosofate
1
gemcitabine-oxaliplatin regimen
1
Tegafur
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
S 1 (combination)
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Nivolumab
1
Microscopy, Confocal
1
Methylation
1
Mass Spectrometry
1
Leucovorin
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Biliary Tract Neoplasms
×
Irinotecan
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled